Thiazepinverbindungen
European patent · EP0240228 · Deleted
Register entry
- Publication number
- EP0240228
- Application number
- EP87302539
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 24, 1987
- Published
- Oct 7, 1987
- Granted
- Nov 7, 1990
- Deleted
- Mar 23, 2007
- Reason
- Maximum term reached
- IPC classes
- C07D 281/16 (2006.01)A61K 31/55 (2006.01)
- Priority
- GB A 8607684 27.03.1986
- Filing language
- English
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 30, 2007
Maximum term reached
Published in +pat+ No 8 in 2007
- Feb 15, 2006
Transferred
- Owner
- Zeneca Inc., Concord Pike & New Murphy Road, Wilmington/DE, USA → AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19803, USA
Published in +pat+ No 3 in 2006
- Dec 14, 1990
Granted
Published in PIDTJ No 23 in 1990
Parties
Inventor
Warawa, Edward John
Wilmington/DE, US
Migler, Bernard Martin
Cherry Hill/NJ, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.